CNBC's Jim Cramer on Monday told investors to be wary of some food and beverage stocks as investors are captivated by companies that make newly popular GLP-1s, weight loss and diabetes drugs such as Mounjaro and Zepbound.
"Stay away from these food and beverage stocks because there will be a day, that day will come, when one of them finally admits they've been hurt by the GLP-1s, and that will take down every stock in the group," he said.
But there are other variables that could contribute to weaker sales for food and beverage companies, he said.
Cramer conceded that it's hard to predict just how much these drugs will affect food stocks going forward, but said they will definitely change the market.
"However, you're fooling yourself if you think these drugs didn't play some sort of role."
Persons:
CNBC's Jim Cramer, they've, Cramer
Organizations:
PepsiCo